Cargando…

Assessing rare diseases prevalence using literature quantification

INTRODUCTION: Estimating the prevalence of diseases is crucial for the organization of healthcare. The amount of literature on a rare pathology could help differentiate between rare and very rare diseases. The objective of this work was to evaluate to what extent the number of publications can be us...

Descripción completa

Detalles Bibliográficos
Autores principales: Jason, Shourick, Maxime, Wack, Anne-Sophie, Jannot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980535/
https://www.ncbi.nlm.nih.gov/pubmed/33743790
http://dx.doi.org/10.1186/s13023-020-01639-7
_version_ 1783667446740156416
author Jason, Shourick
Maxime, Wack
Anne-Sophie, Jannot
author_facet Jason, Shourick
Maxime, Wack
Anne-Sophie, Jannot
author_sort Jason, Shourick
collection PubMed
description INTRODUCTION: Estimating the prevalence of diseases is crucial for the organization of healthcare. The amount of literature on a rare pathology could help differentiate between rare and very rare diseases. The objective of this work was to evaluate to what extent the number of publications can be used to predict the prevalence of a given pathology. METHODS: We queried Orphanet for the global prevalence class for all conditions for which it was available. For these pathologies, we cross-referenced the Orphanet, MeSH, and OMIM vocabularies to assess the number of publication available on Pubmed using three different query strategies (one proposed in the literature, and two built specifically for this study). We first studied the association of the number of publications obtained by each of these query strategies with the prevalence class, then their predictive ability. RESULTS: Class prevalence was available for 3128 conditions, 2970 had a prevalence class < 1/1,000,000, 41 of 1–9/1,000,000, 84 of 1–9/100,000, and 33 of 1–9/10,000. We show a significant association and excellent predictive performance of the number of publication, with an AUC over 94% for the best query strategy. CONCLUSION: Our study highlights the link and the excellent predictive performance of the number of publications on the prevalence of rare diseases provided by Orphanet.
format Online
Article
Text
id pubmed-7980535
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79805352021-03-22 Assessing rare diseases prevalence using literature quantification Jason, Shourick Maxime, Wack Anne-Sophie, Jannot Orphanet J Rare Dis Research INTRODUCTION: Estimating the prevalence of diseases is crucial for the organization of healthcare. The amount of literature on a rare pathology could help differentiate between rare and very rare diseases. The objective of this work was to evaluate to what extent the number of publications can be used to predict the prevalence of a given pathology. METHODS: We queried Orphanet for the global prevalence class for all conditions for which it was available. For these pathologies, we cross-referenced the Orphanet, MeSH, and OMIM vocabularies to assess the number of publication available on Pubmed using three different query strategies (one proposed in the literature, and two built specifically for this study). We first studied the association of the number of publications obtained by each of these query strategies with the prevalence class, then their predictive ability. RESULTS: Class prevalence was available for 3128 conditions, 2970 had a prevalence class < 1/1,000,000, 41 of 1–9/1,000,000, 84 of 1–9/100,000, and 33 of 1–9/10,000. We show a significant association and excellent predictive performance of the number of publication, with an AUC over 94% for the best query strategy. CONCLUSION: Our study highlights the link and the excellent predictive performance of the number of publications on the prevalence of rare diseases provided by Orphanet. BioMed Central 2021-03-20 /pmc/articles/PMC7980535/ /pubmed/33743790 http://dx.doi.org/10.1186/s13023-020-01639-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jason, Shourick
Maxime, Wack
Anne-Sophie, Jannot
Assessing rare diseases prevalence using literature quantification
title Assessing rare diseases prevalence using literature quantification
title_full Assessing rare diseases prevalence using literature quantification
title_fullStr Assessing rare diseases prevalence using literature quantification
title_full_unstemmed Assessing rare diseases prevalence using literature quantification
title_short Assessing rare diseases prevalence using literature quantification
title_sort assessing rare diseases prevalence using literature quantification
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980535/
https://www.ncbi.nlm.nih.gov/pubmed/33743790
http://dx.doi.org/10.1186/s13023-020-01639-7
work_keys_str_mv AT jasonshourick assessingrarediseasesprevalenceusingliteraturequantification
AT maximewack assessingrarediseasesprevalenceusingliteraturequantification
AT annesophiejannot assessingrarediseasesprevalenceusingliteraturequantification